Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.050
+0.240 (13.26%)
At close: May 12, 2025, 4:00 PM
1.940
-0.110 (-5.36%)
After-hours: May 12, 2025, 6:00 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $63.52 million as of May 12, 2025. Its market cap has decreased by -82.39% in one year.
Market Cap
63.52M
Enterprise Value
-2.73M
1-Year Change
-82.39%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $63.52M, a decrease of -82.16%. That is a compound annual growth rate of -79.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 56.10M | -34.69% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |